Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-01-17 @ 10:05 PM
Study NCT ID:
NCT03634059
Status:
UNKNOWN
Last Update Posted:
2018-08-16
First Post:
2018-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations
Sponsor:
Hebei Medical University Fourth Hospital
Organization: